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A Human Coronavirus Responsible for the Common Cold Massively
Kills Dendritic Cells but Not Monocytes
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Matthew L. Albert,c Béatrice Nal,b and Frédéric Tangya
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Department of Anatomy, The University of Hong Kong, Hong Kong, Chinab; Unité d’Immunobiologie des Cellules Dendritiques and Centre d’Immunologie Humaine,
Department of Immunology, Institut Pasteur, INSERM U818, Paris, Francec; and Université de Caen-Basse-Normandie, EA 4655-U2RM, Laboratoire de Virologie, CHU de
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Human coronaviruses are associated with upper respiratory tract infections that occasionally spread to the lungs and other or-
gans. Although airway epithelial cells represent an important target for infection, the respiratory epithelium is also composed of
an elaborate network of dendritic cells (DCs) that are essential sentinels of the immune system, sensing pathogens and present-
ing foreign antigens to T lymphocytes. In this report, we show that in vitro infection by human coronavirus 229E (HCoV-229E)
induces massive cytopathic effects in DCs, including the formation of large syncytia and cell death within only few hours. In con-
trast, monocytes are muchmore resistant to infection and cytopathic effects despite similar expression levels of CD13, the mem-
brane receptor for HCoV-229E.While the differentiation of monocytes into DCs in the presence of granulocyte-macrophage
colony-stimulating factor and interleukin-4 requires 5 days, only 24 h are sufficient for these cytokines to sensitize monocytes to
cell death and cytopathic effects when infected by HCoV-229E. Cell death induced by HCoV-229E is independent of TRAIL,
FasL, tumor necrosis factor alpha, and caspase activity, indicating that viral replication is directly responsible for the observed
cytopathic effects. The consequence of DC death at the early stage of HCoV-229E infectionmay have an impact on the early con-
trol of viral dissemination and on the establishment of long-lasting immunememory, since people can be reinfected multiple
times by HCoV-229E.
Coronaviruses (CoVs) are enveloped positive-strand RNA vi-ruses from the Coronaviridae family. Five members have been
reported to infect humans, including 229E, OC43, the newly dis-
covered NL63 and HKU1, and the emerging SARS-CoV. Human
CoVs (HCoVs) 229E and NL63 are closely related and belong to
the alphacoronavirus genus, whereas OC43, HKU1, and SARS-
CoV belong to betacoronavirus genus. HCoVs infect airways and
are responsible for different respiratory diseases (19, 44). Al-
though the SARS-CoV was associated with a severe acute respira-
tory disease during the 2002–2003 pandemic, most HCoVs cause
only a mild respiratory infection (49). Epidemiological studies
suggest that HCoVs account for 15 to 30% of common colds, with
only occasional spreading to the lower respiratory tract. Airway
epithelial cells represent the primary target of infection (19, 44).
Nevertheless, in vitro experiments demonstrate that other cell
types can be infected. For example, HCoV-229E was reported to
infect and replicate in neural cells, hepatocytes, monocytes, and
macrophages (3, 11, 12). The neurotropism of HCoV-229E and
OC43 has also been documented in vivo, and a possible associa-
tion with multiple sclerosis has been suggested (4). Because pe-
ripheral blood cells from the myeloid lineage can be infected by
HCoVs, these cells have been proposed to serve as a vector for viral
spread to neural tissues (13).
In addition to epithelial cells, the human airway epithelium
possesses an elaborate network of dendritic cells (DCs). DCs serve
as sentinels in the respiratory tract, where they detect inhaled
pathogens through the recognition of pathogen-associated mo-
lecular patterns (PAMPs), e.g., bacterial lipopolysaccharides or
viral nucleic acids. In order to mediate this function, DCs express
pattern recognition receptors (PRRs), e.g., Toll-like receptors,
NOD-like receptors, RIG-like receptors, and C-type lectin recep-
tors. Upon engagement, these receptors induce the migration of
DCs to the draining lymph nodes and their maturation into anti-
gen-presenting cells. This maturation process determines the abil-
ity of DCs to stimulate an adaptive immune response against an-
tigens that have been captured in the lungs. Therefore, these
conventional DCs are at the nexus of innate and adaptive immu-
nity in the lungs.
Several viruses that spread through the airways infect DCs. For
example, infection of DCs by influenza virus induces their matu-
ration and migration to the lymph nodes to efficiently prime an
adaptive immune response (1, 29, 38). In contrast, measles virus
(MV) uses DCs as a Trojan horse to spread from the lungs to other
tissues (14, 15), while still inducing long-term immune responses.
Although MV-infected DCs migrate properly to lymph nodes,
their phenotypic maturation is perturbed, and infected DCs fail to
stimulate interacting lymphocytes (42), indicating that cross-
priming by uninfected DCs might be the route for eliciting an MV
adaptive immune response (43). In addition, activation signals
provided by lymphocytes dramatically enhance MV replication
within infected DCs, and this likely contributes to the establish-
ment of viremia (42). Thus, DC infection has different effects in
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disease pathogenesis, depending on the host-pathogen interac-
tions. Indeed, DC infection supports priming of T cells, and yet
infection of a migrating cell also contributes to the spread of the
virus to distal tissues.
CoVs associated with the common cold, such as HCoV-229E,
are likely to interact with lung DCs in vivo. However, the suscep-
tibility of DCs to infection by these viruses is as yet unknown. We
describe here the in vitro infection of monocyte-derived DCs (Mo-
DCs) with human HCoV-229E. Infection resulted in dramatic
cytopathic effects, with the formation of large syncytia, and cell
death occurred within 24 h. In contrast, infected monocytes from
the same donors were preserved from cytopathic effects and ac-
quired sensitivity to cell death only after a short stimulation with
granulocyte-macrophage colony-stimulating factor (GM-CSF)
and interleukin-4 (IL-4). Different hypotheses were tested to ex-
plain this observation.
MATERIALS AND METHODS
Production of HCoV-229E virus stocks and in vitro infection. Virus
stocks were established on MRC5 cells using HCoV-229E virus strain
from ATCC (VR-740). After washing, 80 to 90% confluent cell cultures
were infected in a minimal volume of serum-free medium for 2 h. Dul-
becco modified Eagle medium (DMEM) containing 10% fetal calf serum
(FCS) and antibiotics was added, and infected cultures were incubated for
4 to 5 days at 37°C and 5% CO2. The cytopathic effect was monitored by
optical microscopy. Cell supernatants were harvested, centrifuged for 5
min at 4,000 rpm, and aliquoted into cryotubes for storage at 80°C.
Virus titers were determined as 50% tissue culture infective doses
(TCID50). MRC5 cells were seeded in 96-well plates and inoculated with
serial dilutions of virus stock ranging from 101 to 108. Plates were
incubated for 12 h at 37°C before adding DMEM supplemented with 10%
FCS. The plates were incubated for another 6 days and then fixed with 4%
paraformaldehyde before being stained with crystal violet. Infected wells
were numbered for each virus dilution, allowing us to calculate a TCID50
(26, 45). To perform in vitro infections, cell suspensions of monocytes,
Mo-DCs, or CD34-DCs were incubated for 2 h at 37°C with an appropri-
ate volume of virus stock to match the indicated multiplicity of infection
(MOI). Mock infections were performed using supernatant from unin-
fected MRC5 cell cultures. Finally, cells were dispensed at 106 cells/ml and
harvested at the indicated time points.
Detection of HCoV-229E replication. Viral replication was assessed
in culture supernatants of infected cells by quantitative reverse transcrip-
tion-PCR (qRT-PCR). Viral RNA was extracted from medium using an
automated QiaSymphony system (Qiagen). HCoV-229E-specific primers
and probe previously designed and targeting the HCoV-229E N gene were
used (17). The viral quantification was calculated by using an external
standard curve constituted by serial 10-fold dilutions of viral RNA tran-
scripts (108 to 102 copies). These transcripts were in vitro transcribed
with T7 polymerase from pCR-XL-TOPO plasmids containing the M and
N genes of HCoV-229E previously cloned from HCoV-229E (strain
ATCC-VR-740) MRC5 cell culture supernatants. The RNA transcripts
were quantified in a UV spectrophotometer.
Production of SARS-CoV stocks and in vitro infection. Virus stocks
were established on VeroE6 cells using the FFM-1 strain of SARS-CoV
(kindly provided by H. W. Doerr, Institute of Medical Virology, Frankfurt
University Medical School, Frankfurt, Germany), as previously described
(7). All viral stocks were stored at 80°C in single-use aliquots and
titrated in a standard limiting dilution assay on FRhK-4 cell monolayers.
Infectious titers were determined as the TCID50 with optical microscopic
reading of the cytopathic effect as described above. All work involving
infectious SARS-CoV was performed in an enhanced biosafety level 3
containment laboratory with rigorous safety procedures according to
World Health Organization (WHO) guidelines. In vitro infections of
monocytes, Mo-DCs, or CD34-DCs with SARS-CoV were performed as
described above for HCoV-229E infections. Mock infections were per-
formed using supernatant from uninfected VeroE6 cell cultures.
Preparation of monocytes and Mo-DCs. Blood cells were obtained
from leukapheresis samples freshly collected from normal donors after
informed consent was obtained and according to institutional guidelines.
Mononuclear cells were separated on a Ficoll-Hypaque gradient (density,
1.077 /ml). CD14 cells corresponding to monocytes were purified by
positive selection using immunomagnetic beads coated with anti-CD14
MAbs (Miltenyi Biotech, Cologne, Germany). Purity was assessed by anti-
CD14 immunostaining and flow cytometry analysis (Pharmingen, San
Diego, CA). DC-SIGN and BDCA-1 populations were also purified by
positive selection using immunomagnetic beads. CD14 cells were plated
at 2  106 cells/ml in RPMI 1640 medium containing 10% FCS in the
presence of IL-4 (20 ng/ml; Gentaur Molecule Products, Belgium), and
GM-CSF (100 ng/ml; Gentaur Molecule Products, Belgium). Monocyte
differentiation into Mo-DCs was obtained in 5 days as previously de-
scribed (10). In some experiments, DC maturation was induced using
trimeric CD40-L (250 ng/ml; R&D Systems) or tumor necrosis factor
alpha (TNF-; 5 ng/ml; R&D Systems) plus prostaglandin E2 (PGE2; 1
g/ml), or polyinosinic-poly(C) sodium salt (poly-IC; 1 g/ml; Sigma).
Preparation of CD34-DCs. Peripheral blood CD34 cells were puri-
fied from leukapheresis products collected from patients after stem cell
mobilization with granulocyte colony-stimulating factor (G-CSF) and cy-
clophosphamide. Permission to obtain leukapheresis samples was ob-
tained after obtaining informed consent from the patients and approval
by the institutional review board. CD34 cells were purified using immu-
nomagnetic beads as described elsewhere (32). Differentiation of CD34
cells into CD34-DCs was adapted from Movassagh et al. (32). Briefly,
CD34 cells were cultured for 10 days. The medium was changed at days
3, 5, and 8, and cells were seeded at 2 106 cells/ml in RPMI containing
10% FCS, 1% glutamine, 2% antibiotics, 100 ng of GM-CSF/ml, 50 ng
of SCF/ml, 50 ng of IL-4/ml, 5 ng of TNF-/ml, and 300 ng of Flt3-L/
ml. At day 10, the CD34 cells had achieved their differentiation into
CD34-DCs.
MAbs and flow cytometry analysis. Fluorescein isothiocyanate
(FITC)-conjugated anti-CD14, phycoerythrin (PE)-conjugated anti-
CCR7, allophycocyanin (APC)-conjugated anti-CD83, FITC-conjugated
anti-CD14, APC-conjugated anti-CD209 (DC-SIGN), PE-conjugated
anti-TRAIL, FITC-conjugated anti-active caspase-3, PE-conjugated anti-
caspase-3, and APC-conjugated anti-CD13 monoclonal antibodies
(MAbs) were from Pharmingen (San Diego, CA). HCoV-229E spike gly-
coprotein was detected using MAb 5-11H.6 (2, 19). The SARS-CoV
anti-M serum recognizes the C-terminal domain of SARS-CoV mem-
brane (M) protein (Proscience, Poway, CA). TRITC (tetramethyl rhoda-
mine isothiocyanate)-conjugated goat anti-mouse secondary antibody
was from Zymed Laboratories (San Francisco, CA), and Alexa Fluor 488
goat anti-rabbit was from Invitrogen Molecular Probes (Eugene, OR).
Negative controls were appropriate irrelevant isotype-matched MAbs.
For immunostaining, 2 105 cells were washed twice with phosphate-
buffered saline (PBS) and 2% FCS and then fixed in PBS containing 4%
paraformaldehyde (PFA). Cells were permeabilized or not with Perm-
Wash buffer (BD Bioscience), incubated with the appropriate MAb at 4°C
for 20 min, and washed in PBS before analysis by flow cytometry using a
FACSCalibur (Becton Dickinson). At least 20,000 gated events were col-
lected and analyzed with FlowJo software (Tree Star). The results are
expressed as a percentage of positive cells and/or as the mean fluorescence
intensity compared to negative controls. Dead cells were stained accord-
ing to the manufacturer’s instructions with the Dead/Live cell kit (Invit-
rogen Corp., Carlsbad, CA).
Cell culture imaging. Monocytes or Mo-DCs were infected with
HCoV-229E at an MOI of 0.05 and with SARS-CoV at an MOI of 1 and
cultured in the culture chambers of microscopy slides (Ibidi, Munich,
Germany). At 24 h postinfection, the cells were fixed for 15 min with 4%
PFA for HCoV-229E and 1 h for SARS-CoV, for safety reasons. Free alde-
hyde groups were quenched in 50 mM NH4Cl, and the cells were perme-
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abilized for 5 min at 4°C in PBS containing 0.1% Triton X-100. The cells
were incubated for 1 h in PBS supplemented with 5% goat serum and
incubated again in the same solution containing the respective viral anti-
body: anti-spike glycoprotein MAb 5-11H.6 for HCoV-229E-infected
cells and anti-M antibody (Proscience) for SARS-CoV experiments.
HCoV-229E- and SARS-CoV-infected cells were washed twice with PBS
and incubated for 1 h with a respective secondary antibody. Finally, the
cells were washed with PBS and stained for 5 min with a PBS solution
containing DAPI (4=,6=-diamidino-2-phenylindole). After a wash with
PBS, 100l of Fluoromount-G was added to the wells (Southern Biotech,
Birmingham, AL). The slides were analyzed, and image acquisition was
performed using fluorescence microscope using a 40 oil immersion
objective lens.
Human primary Mo-DCs were infected with HCoV-229E at an MOI
of 0.05 and incubated for 11 h at 37°C in the culture chamber of a micros-
copy slide (Ibidi). The microscopy slide was then placed under an optical
microscope for live cell imaging. Snapshots were captured every 30 s over
a period of 9 h using a 10 objective lens and a 1.5 magnifying lens.
Finally, images were compiled into a movie and played back at 24
frames per s.
Cytokine detection and neutralization. Cytokines produced from
monocytes and Mo-DCs were measured from cell culture supernatants by
using a multiplex bead-based Luminex assay (Biosource; Invitrogen
Corp.) according to the manufacturer’s instructions. IFN-/production
was determined by enzyme-linked immunosorbent assay (ELISA) ac-
cording to the manufacturer’s instructions (PBL Interferon Source, Pis-
cataway, NJ). For the neutralization of type I IFNs, monocytes were
treated with sheep polyclonal antibody against human IFN- (2,000 IU/
ml; PBL Biomedical Laboratories, Piscataway, NJ) and with sheep poly-
clonal antibody against human IFN- (500 IU/ml; PBL Biomedical Lab-
oratories). For neutralization of human IL-6 bioactivity, monocyte
cultures were treated with anti-human IL-6 antibody (10 g/ml; R&D
Systems).
Apoptosis and infection inhibition. To block apoptosis, Mo-DCs
were incubated prior to infection with caspase inhibitor Z-VAD-FMK
(BD Biosciences) for 30 min at room temperature and then maintained in
cell culture medium. Similar experiments were performed to block apop-
tosis using hIL-6 (100 ng/ml; Miltenyi Biotech) and hIFN- (PBL Bio-
medical Laboratories). To inhibit death ligand signaling, Mo-DCs were
treated during and after infection with either an anti-hTRAIL MAb (100
ng/ml; R&D Systems), a recombinant human Fas-Fc chimera (1 g/ml;
R&D Systems), or a recombinant human TNFR-Fc chimera (1 g/ml;
R&D Systems). To block HCoV-229E infection, Mo-DCs were treated 1 h
at room temperature with 15 g of anti-CD13 MAb (Biolegend, San Di-
ego, CA) prior to infection as described elsewhere (39). Anti-CD13 was
maintained in cell culture medium.
RESULTS
HCoV-229E induces massive cytopathic effects in Mo-DC cul-
tures but not in monocytes. Although CoVs associated with the
common cold, such as HCoV-229E, are likely to interact with DCs
in the upper respiratory tract, the in vitro susceptibility of human
DCs to infection by these viruses is not yet known. To address this
question, we infected human primary monocytes and monocyte-
derived DCs (Mo-DCs) with HCoV-229E. We first assessed the
expression on the surface of monocytes and Mo-DCs of amino-
peptidase N (CD13), a membrane-bound metalloprotease previ-
ously identified as a receptor for human HCoV-229E (52). CD13
is expressed on epithelial cells from the lungs and the intestine but
also on monocytes, granulocytes, and neuronal cells. Both mono-
cytes and Mo-DCs expressed high levels of CD13 (Fig. 1D). Hu-
man primary monocytes and Mo-DCs were then infected with
HCoV-229E at an MOI of 0.05 and cultivated for 24 h. Bright-field
observation of cells at 24 h postinfection revealed a massive cyto-
pathic effect in Mo-DCs, whereas monocyte cultures remained
largely unaffected (Fig. 1A). The cytopathic effect in Mo-DCs was
assessed by the presence of cellular aggregates, large syncytia, and
numerous cellular debris. Infectious virus was required for killing
cells since no cytopathic effect was observed when HCoV-229E
virus was UV inactivated (Fig. 1A, right panel). To evaluate the
kinetics of cell death after infection, time-lapse microscopy was
recorded on infected Mo-DC cultures (see Movie S1 in the sup-
plemental material). This recording started 11 h after infection,
and snapshots were captured every 30 s for 9 h. Small syncytia
connected to each other by branched projections were visible as
early as 11 h postinfection. These structures progressively fused
with neighboring cells to form large syncytial structures. Finally, a
rapid and near complete lysis of both syncytia and isolated cells
was observed at 20 h postinfection.
To quantify cell death induced by HCoV-229E in Mo-DC cul-
tures, we determined the number of living cells in infected cul-
tures by trypan blue exclusion at different time points and differ-
ent MOIs, including 0.05, 0.1, and 0.5 (Fig. 1B). Cell death was
massive in Mo-DC cultures, even at the lowest MOI of 0.05, with
virtually no viable cells detected at 24 h postinfection. In contrast,
monocytes were resistant to cell death, with limited loss of viable
cells at 48 h after inoculation, even with the highest MOI of 0.5. In
the same experiment, we also quantified the status of caspase-3
activation since this protease plays a central role in the execution
phase of programmed cell death. In agreement with our observa-
tion showing that only Mo-DCs were killed by HCoV-229E infec-
tion, caspase-3 was activated in Mo-DCs but not in monocytes
(Fig. 1C). Thus, the death of Mo-DCs induced after HCoV-229E
infection is associated with caspase-3 activation. We then com-
pared the effects of SARS-CoV, which is much more pathogenic in
humans than HCoV-229E and spreads to lower respiratory tract,
possibly through dendritic cell transfer (51). Although viral infec-
tion was detected by anti-spike and anti-M immunostaining, no
cytopathic effect was induced by SARS-CoV infection in Mo-DCs
(Fig. 1E), in agreement with previous reports (28, 46). The same
result was obtained when a 20-fold-higher MOI of SARS-CoV was
used (data not shown). Altogether, these observations show that
HCoV-229E (but not SARS-CoV) induces massive cytopathic ef-
fects in Mo-DC cultures, whereas monocytes do not exhibit this
unusual susceptibility.
Mo-DCs, but not monocytes, are highly susceptible to
HCoV-229E infection. To determine whether cytopathic effects
of HCoV-229E correlate with a higher susceptibility to infection,
Mo-DCs and monocytes were infected, cultured, and then immu-
nostained for the expression of viral spike glycoprotein. As ex-
pected, the large syncytia of Mo-DCs were positive for HCoV-
229E spike protein expression, thus demonstrating viral infection
(Fig. 2A). In contrast, only a small fraction of monocytes ex-
pressed the viral spike glycoprotein after exposure to a similar
inoculum of HCoV-229E, and no cell fusion occurred. Immuno-
staining and flow cytometry analysis of infected cells revealed that
a large fraction of Mo-DCs (85%) expressed the spike glycopro-
tein of HCoV-229E at 10 h postinfection, while only a few mono-
cytes were positively stained regardless of the MOI used (Fig. 2B).
These results suggest that Mo-DCs are much more susceptible to
infection by HCoV-229E than are monocytes. This was confirmed
when viral RNA load was measured by qRT-PCR in cell cultures
supernatants (Fig. 2C). Viral RNA load increased during the first 8
h postinfection in both Mo-DCs and monocytes, thus demon-
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strating viral replication, but was much higher in Mo-DC cultures.
Interestingly, the viral RNA load detected in monocyte cultures
increased when cells were infected with a higher MOI, thus dem-
onstrating that monocytes are permissive to HCoV-229E infec-
tion, but Mo-DCs are clearly much more susceptible. Further-
more, HCoV-229E never induced massive cytopathic effects in
monocyte cultures, even when performing infections with higher
MOIs (Fig. 1B, right panel). In conclusion, Mo-DCs are not only
more susceptible to viral replication but also to HCoV-229E-in-
duced cytopathic effects.
Blocking cell entry or replication of HCoV-229E into Mo-
DCs prevents cytopathic effects. Once inside Mo-DCs, HCoV-
FIG 1 Cytopathic effects of HCoV-229E on Mo-DCs. (A) Bright-field microscopy of monocytes and Mo-DC cultures either mock treated or infected with
HCoV-229E (MOI 0.05) and then cultured for 24 h. (B) Monocytes () and Mo-DCs (Œ) were infected with HCoV-229E at MOIs of 0.05, 0.1, and 0.5. Viable
cells were enumerated at the indicated time points by trypan blue exclusion (mean of three donors). (C) Detection of the active form of caspase-3 in HCoV-
229E-infected Mo-DCs and monocytes by cytometry (the results of one representative experiment out of five are shown). (D) CD13 expression on monocytes
and Mo-DCs. Cells were stained with an anti-CD13 MAb (open line) or an isotypic control (closed line) and analyzed by flow cytometry. The data shown are
representative of three different donors. (E) Mo-DCs infected with SARS CoV (MOI 1 for 24 h). The upper part shows a bright-field image of Mo-DCs either
mock treated or infected with SARS-CoV. The lower part shows the immunostaining of viral spike glycoprotein and membrane envelope protein (M) (red,
anti-spike; green, anti-M; blue, DAPI). The data are representative of three independent experiments.
Mesel-Lemoine et al.
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229E replicates actively, as demonstrated by cell surface expres-
sion of the viral spike glycoprotein and detection of the viral RNA
load (Fig. 2). Interestingly, UV-inactivated virus was ineffective at
inducing cytopathic effect in Mo-DCs, suggesting that viral repli-
cation in infected cells is linked to the cytopathic effect (Fig. 1A,
right panel). To demonstrate that HCoV-229E-induced cyto-
pathic effects and cell death are dependent on viral entry, Mo-DC
infection was performed in the presence of anti-CD13 MAb to
block virus binding to its receptor. Pretreating Mo-DC cultures
with anti-CD13 MAb protected cells from virus-induced cyto-
pathic effects (Fig. 3A), confirming that virus entry into Mo-DCs
is essential. In addition, we tested whether type I IFN (IFN-)
could rescue Mo-DCs from HCoV-229E-induced cytopathic ef-
fects. Indeed, IFN-/ are essential antiviral cytokines that can
control viral replication by inducing a large cluster of immune
factors. Mo-DCs were pretreated with increasing doses of IFN-
for 24 h before HCoV-229E infection. As shown in Fig. 3B, even a
low dose of IFN- (100 IU/ml) was sufficient to prevent HCoV-
229E replication, cytopathic effects, and massive cell death in
Mo-DC cultures. Altogether, these results demonstrate that
HCoV-229E-induced cytopathic effects require viral entry in Mo-
DCs and sustained viral replication.
Different populations of conventional DCs show a similar
susceptibility toHCoV-229E-induced cytopathic effects.Several
subsets of conventional DCs have been described (20, 30, 35, 36).
To determine whether other DC populations also show a high
susceptibility to HCoV-229E, we tested DCs derived from CD34
precursor cells (9, 40). Mo-DCs and CD34-derived DCs (CD34-
DCs) show similar morphologies and antigen uptake/presenta-
tion capacities (18, 24). We first demonstrated that CD34-DCs
express significant amounts of CD13 on their surface (Fig. 4B).
Then, we investigated whether this DC population was as suscep-
tible as Mo-DCs to HCoV-229E infection. We observed massive
cell death at 24 h postinfection in both DC populations, as deter-
mined by trypan blue exclusion (Fig. 4A). Furthermore, infection
of CD34-DCs with HCoV-229E was assessed by viral spike gly-
coprotein expression on their surface (Fig. 4C), thus demonstrat-
ing viral infection. Caspase-3 activation was also observed in
HCoV-229E-infected CD34-DCs (Fig. 4D). In addition, we also
tested peripheral blood DCs purified on the basis of BDCA-1 or
DC-SIGN expression (BDCA-1-DCs or DC-SIGN-DCs). Both
BDCA-1-DCs or DC-SIGN-DCs rapidly died upon HCoV-
229E infection similarly as for Mo-DCs (Fig. 4A). Altogether,
these results show that all tested populations of conventional DCs
are highly susceptible to HCoV-229E-induced cell death.
Together, GM-CSF and IL-4 induce monocyte differentiation
into immature DCs. However, DCs’ ability to stimulate T cells still
requires their maturation into professional antigen-presenting
FIG 2 Susceptibility of monocytes and Mo-DCs to HCoV-229E. (A) Viral spike (S) glycoprotein expression in monocytes and Mo-DC cultures mock treated or
infected with HCoV-229E (MOI  0.05) and then cultured for 10 h (red, anti-spike immunostaining; blue, DAPI staining). (B) Cell surface expression of
HCoV-229E spike glycoprotein on mock-treated and HCoV-229E-infected cells (the results of one representative experiment out of three are shown). (C)
Kinetics of viral RNA produced in medium from monocytes and Mo-DCs infected with HCoV-229E at MOIs of 0.05, 0.1, and 0.5 (mean of two donors).
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cells. This maturation is induced by PAMPs or by cellular factors
such as CD40L, TNF-, or PGE2. To determine whether Mo-DCs’
susceptibility to HCoV-229E infection depends on their matura-
tion state, we preincubated cells in the presence of poly-IC,
CD40L, or PGE2TNF- for 16 h before infection with HCoV-
229E, and the expression of CD80 and HLA-DR maturation
markers was analyzed. Mo-DCs cultured 16 h in the presence of
poly-IC, CD40L, or PGE2TNF- upregulated the expression of
CD80 and HLA-DR (Fig. 4E). However, regardless of the matura-
tion agent used, Mo-DC maturation did not confer resistance to
infection and did not protect cells from HCoV-229E-induced cell
death (Fig. 4F).
Cell death induced by HCoV-229E infection is independent
of FasL, TRAIL, and TNF-. Death receptors are transmembrane
proteins that transmit apoptotic signals initiated by specific li-
gands such as FasL, TNF-, and TRAIL. They recruit and activate
cysteine proteases of the caspase family that are essential media-
tors of programmed cell death or apoptosis and were found to be
activated in HCoV-229E-infected Mo-DCs (Fig. 1C). To evaluate
the role of FasL, TNF-, and TRAIL receptors on the death in-
duced by HCoV-229E infection of Mo-DCs, we neutralized the
binding of these ligands during infection by using different inhib-
itors: an anti-TRAIL MAb, a recombinant human TNFR-Fc chi-
mera, and a recombinant human Fas-Fc chimera (Fig. 5A). We
observed that blocking Fas, TNF-, or TRAIL pathways did not
rescue Mo-DCs from HCoV-229E-induced death. We controlled
in Jurkat cells that anti-TRAIL, TNF-R/Fc, and FAS/Fc were effi-
cient to block apoptosis induced by their cognate ligands, i.e.,
TRAIL, TNF-, and FasL, respectively (data not shown). Caspases
can be activated through pathways that are independent of mem-
brane death receptors. To determine whether cell death induced
by HCoV-229E relies on caspases, we pretreated cells with
Z-VAD-FMK, a general caspase inhibitor that irreversibly blocks
their catalytic site (48). As shown in Fig. 5B, Z-VAD-FMK did not
prevent the death of HCoV-229E-infected Mo-DCs. We con-
trolled in Jurkat cells that Z-VAD-FMK efficiently blocked the
apoptosis induced by TNF- (data not shown). Altogether, these
observations suggest that even if HCoV-229E infection activates
caspases in Mo-DC (Fig. 1C), cell death does not require caspase
activation but rather results from cytolysis and/or necrosis of
multinucleated syncytia induced by replicative infection.
Cytokines produced by monocytes do not account for their
resistance to HCoV-229E-induced cell death and cytopathic ef-
fects. We searched for cellular soluble factors that could account
for monocyte resistance to HCoV-229E-induced cell death and
cytopathic effects. Specific cytokines such as IFN-/ and IL-6
could provide resistance to viral infection. We performed multi-
plex bead-based Luminex assays and ELISA to determine the cy-
tokine/chemokine expression profiles in culture supernatants of
monocytes and Mo-DCs collected 6, 12, and 24 h after infection
with HCoV-229E. The results obtained at 24 h are presented in
Table 1. Tested cytokines and chemokines were all induced in
monocytes as soon as 6 h after infection with HCoV-229E, reach-
ing prominent inductions of TNF- (27), IFN- (19), MCP1
(16), IL-6 (11), and IFN-	 (9) at 24 h. In contrast, for Mo-
DCs, no increased induction was observed at early time points
(not shown), and a more restricted induction profile limited to
IFN- (24), IL-8 (16), and TNF- (9) at 24 h after infection.
Some of these cytokines that were differentially induced, such as
IL-6, could account for the resistance of monocytes to HCoV-
229E infection, cytopathic effects, and cell death. To test this hy-
pothesis, Mo-DCs were pretreated for 24 h with UV-inactivated
supernatants from infected monocyte cultures. Then, Mo-DCs
susceptibility to infection by HCoV-229E was determined. As
shown in Fig. 6A, monocyte culture supernatant did not confer
resistance to HCoV-229E-induced cell death and cytopathic ef-
FIG 3 Role HCoV-229E cell entry and replication on Mo-DC death. (A) Mo-DCs were incubated or not with anti-CD13 MAb prior to infection with
HCoV-229E. Cell death was determined by the observation of cytopathic effects and the formation of syncytia by bright-field microscopy (the results of one
representative experiment out of three are shown). (B) Mo-DCs were treated or not with increasing amounts of IFN- prior to infection with HCoV-229E, and
the percentages of cells expressing spike viral protein or activated caspase-3 were determined by flow cytometry (the results of one representative experiment out
of three are shown).
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fects. Thus, resistance of monocytes to HCoV-229E-induced cell
death is probably not mediated by a soluble factor but rather relies
on an intrinsic property of this cell type that is lost during differ-
entiation into Mo-DCs. It should be noted that monocyte culture
supernatants contained 113 pg of IFN-/ml and 31 pg of IFN-
/ml (Table 1), which correspond to 17 and 5 IU/ml, respectively.
These levels are much lower than the 100- to 1,000-IU/ml doses of
IFN-used to inhibit HCoV-229E replication in Mo-DCs in Fig. 3B.
HCoV-229E susceptibility is early acquired during mono-
cyte differentiation into Mo-DCs. The differentiation of mono-
cytes into immature DCs is usually achieved after 5 days of culture
in the presence of both GM-CSF and IL-4. To determine at which
stage of differentiation monocytes acquire their susceptibility to
infection, we cultivated purified CD14 monocytes either in me-
dium alone or in GM-CSF, IL-4, or both cytokines. At different
time points, cells were harvested and tested for the induction of
cytopathic effects by HCoV-229E infection (MOI of 0.05). After
only 24 h of culture in the presence of both GM-CSF and IL-4,
although cells retain a cell surface phenotype of monocytes, ex-
pressing CD14 but no CD11c (Fig. 6B), they became susceptible to
HCoV-229E, as assessed by the presence of large syncytia, dead
cells and cellular debris (Fig. 6C, upper panel). Again, this suscep-
tibility paralleled with high levels of viral spike glycoprotein ex-
pression and activation of caspase 3 (Fig. 6C, lower panel). The
strong increase of viral spike protein on cell membrane, as in Mo-
DCs, argues that this protein, which is responsible for membrane
fusion, is the cause of syncytia formation and cell death. Interest-
ingly, monocytes treated with IL-4 alone also became susceptible
to HCoV-229E infection, and massive cytopathic effects were ob-
served. A similar trend was observed when treating monocytes
with GM-CSF alone, but the cytopathic effects were much less
pronounced. This suggests that signaling events predominantly
induced by IL-4, but partially overlapping with GM-CSF, are re-
sponsible for monocytes sensitization.
DISCUSSION
Although infection with the emerging SARS-CoV was associated
with a severe acute respiratory disease, most human CoVs are
FIG 4 Killing of conventional DCs by HCoV-229E. (A) CD34-DCs, BDCA-1-DCs, and DC-SIGN-DCs were either mock treated (open symbols) or infected with
HCoV-229E (closed symbols) at different MOIs (0.05, 0.1, and 0.5). Viable cells were enumerated at the indicated time points by trypan blue exclusion (mean of two
donors). (B, C, and D) CD34-DCs were infected with HCoV-229E, cultured for 24 h, and then immunostained for CD13, spike glycoprotein, or active caspase-3
expression. Cells were analyzed by flow cytometry. (E) Mo-DCs were treated with poly-IC, CD40L, or PGE2TNF- to induce maturation and then infected with
HCoV-229E. The CD80 and HLA-DR expression levels were determined by flow cytometry. (F) Cell death was determined by using Dead/Live staining.
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responsible for mild upper respiratory tract infections, such as
common colds, with only occasional spreading to the lower respi-
ratory tract. Most respiratory viruses interact with DCs in the
upper respiratory tract, which results in initiating an antiviral im-
mune response but may also result in the spreading of the virus as
a result of DC migration to the draining lymph nodes. In the
present study, we investigated the interaction between HCoV-
229E and human DCs. We observed that HCoV-229E infection
causes massive cytopathic effects, resulting in the rapid death of
DCs. Cell death correlates with a high surface expression of the
HCoV-229E spike protein, which is responsible for cell-cell fu-
sion, and the formation of large syncytia that blow up in a very
short time (10 h, see the Movie S1 in the supplemental material).
In contrast, monocytes from the same donors are less susceptible
to infection and resist cytopathic effects and cell death despite
similar expression levels of CD13, the cell surface receptor for
HCoV-229E. Monocytes rapidly acquire susceptibility to HCoV-
299E infection upon a short differentiation in the presence of
GM-CSF and/or IL-4. DC differentiation might downregulate a
restriction factor present in monocytes or induce the expression of
an unknown cellular factor increasing susceptibility to HCoV-
229E infection such as a coreceptor on the surface of the DCs. The
infection and killing of DCs is dependent upon viral entry and
viral replication, since blocking virus entry with an anti-CD13
antibody or inactivating the virus with UV protected cells. Pre-
treating cells with blocking antibodies against TNF-, FAS-L,
TRAIL, and IFN-/ or with the caspase inhibitor Z-VAD-FMK
did not protect infected Mo-DCs from death. We therefore sug-
gest that cell death induced by HCoV-229E is not an apoptotic
process but rather a direct consequence of virus replication and
viral spike protein expression on the cell surface. Consistent with
this interpretation, the only situation in which we observed pro-
tection was when cells were pretreated with IFN-, which pre-
vented infection by HCoV-229E. However, when Mo-DCs were
infected with HCoV-229E and only then treated with IFN-, viral
replication occurred, inducing cytopathic effects and massive cell
death (data not shown). This suggests that, as previously described
for other respiratory viruses (5, 6), HCoV-229E encodes a viru-
lence factor that blocks IFN-/ signaling and prevents the induc-
FIG 5 Death of HCoV-229E-infected Mo-DCs is independent of TRAIL,
TNF-, FasL, and caspase activity. (A) Mo-DCs were infected with HCoV-
229E and incubated for 24 h in the presence of anti-TRAIL blocking antibod-
ies, TNFR-Fc chimera, or FAS-Fc chimera. Cell death was determined by
trypan blue exclusion (the results of one representative experiment out of three
are shown). (B) Inhibition of caspase activity does not prevent cell death in
Mo-DC cultures. Mo-DCs were preincubated for 24 h in the presence of Z-
VAD-FMK, a potent broad-spectrum caspase inhibitor, and then infected by
HCoV-229E in the presence of Z-VAD-FMK. After 24 h of culture, cell death
was determined by using Dead/Live staining (the results if one representative
experiment out of three are shown).
TABLE 1 Cytokine and chemokine levels detected in culture supernatants from mock- and HCoV-229E-infected monocytes and Mo-DCs at 24 h
postinfection
Cytokine
Mean cytokine concna (pg/ml)
 SD in:
Monocytes Mo-DCs
Mock 229E Fold increase Mock 229E Fold increase
IL-6 87 
 6 937 
 508 11 7 
 5 7 
 2 1
IL-8 15,295 
 9,444 31,297 
 2,656 2 122 
 5 1,891 
 1,107 16
IL-12 20 
 14 87 
 4 4 22 
 11 37 
 19 2
IL-15 33 
 11 187 
 18 6 72 64 
 8 0.9
TNF- 2 
 1 54 
 17 27 4 
 1 34 
 29 9
IFN-	 7 
 1 64 
 2 9 0 4 
 1 4
IFN- 6 
 4 113 
 6 19 6 
 4 141 
 47 24
IFN- 9 
 2 31 
 15 3 9 
 2 27 
 15 3
MIP-1 40 
 2 340 
 73 9 19 
 2 37 
 16 2
MIP-1 893 
 393 4,363 
 192 5 119 
 112 223 
 108 2
RANTES 39 
 1 173 
 8 4 37 
 4 18 
 8 0.5
MCP-1 564 
 234 8,821 
 4,929 16 128 
 7 240 
 58 2
a All cytokines and chemokines were measured by a multiplex bead-based Luminex assay (mean of three donors), except for IFN- and IFN-, which were measured by ELISA
(mean of six donors). The fold increase for mock-infected versus HCoV-229E-infected cells is also indicated.
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tion of antiviral IFN-stimulated genes in Mo-DCs. This might
explain why endogenous type I IFNs induced after HCoV-229E
infection are unable to block viral replication and cytopathic ef-
fects in Mo-DCs. Monocytes exposed to HCoV-229E also re-
sponded by producing type I IFNs, and yet the blockade of IFN-
/ binding did not alter susceptibility to infection. Altogether,
this suggests that monocyte resistance to HCoV-229E-induced
cytopathic effects is independent of endogenous type I IFN pro-
duction but rather relies on the expression of an as-yet-unknown
restriction factor or the absence of a cellular factor increasing sus-
ceptibility to viral infection such as a coreceptor.
Because DCs are major sensors to detect viral infection and
prime adaptive immunity, viruses have evolved strategies to inter-
fere with their development, maturation, function, or viability to
suppress or escape immune response. In this regard, killing DCs
can be an efficient viral strategy to delay or prevent the establish-
ment of adaptive immune responses. Infections by measles virus,
human immunodeficiency virus, or lymphocytic choriomeningi-
tis virus deplete DC populations in infected hosts (12, 22, 37). In
vitro experiments have also demonstrated that filoviruses, vaccinia
virus, herpes simplex virus, H5N1 influenza virus, and measles
virus induce DC apoptosis or cytolysis within a few days (16, 31,
33, 41, 47). Also, human echovirus is extremely cytopathic toward
DCs and induces their death in less than 24 h (27). DC killing by
HCoV-229E, if it happens in vivo in human infection, could delay
the induction of an adaptive immune response, thus providing
time to replicate in the infected host. Furthermore, this could
affect the establishment of a long-term immunological memory to
the virus, explaining why people can be reinfected multiple times
by HCoV-229E (8).
Massive death of infected DCs may also act as a host defense
mechanism to prevent virus spreading in the body. Because DCs
are located at every possible entry site of the body, they are one of
the first cell types encountered by incoming viruses. Upon stimu-
lation by PAMPs, DCs migrate from peripheral tissues to the
draining lymph nodes where they elicit antigen-specific T lym-
phocytes. Many viruses use DCs not only as a vehicle to penetrate
draining lymphoid organs but also to interfere with their antigen-
FIG 6 Analysis of monocyte resistance to cytopathic effects and cell death. (A) Mo-DCs were infected with HCoV-229E at an MOI of 0.05 after preincubation
for 24 h with culture supernatants from mock-treated monocytes, HCoV-229E-infected monocytes, or UV-treated supernatants from HCoV-229E-infected
monocytes. Viable cells were enumerated at the indicated time points by trypan blue exclusion. The results correspond to the mean of three donors. (B)
Phenotype analysis of monocytes incubated for 24 h in the presence of GM-CSF and IL-4. Cells were stained with an anti-CD14 MAb or anti-CD11c (open lines)
or an isotypic control (closed lines) and analyzed by flow cytometry. The data shown are representative of three different donors. (C) Monocytes become
susceptible to HCoV-229E-induced cell death when induced to differentiate into Mo-DCs. Monocytes were treated for 24 h with GM-CSF, IL-4, or both
combined and then infected with HCoV-229E. After 24 h, the cells were immunostained for spike glycoprotein and active caspase-3 expression.
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presenting cell functions so that the immune response is skewed
toward inappropriate cytokine profiles. In the case of HCoV-
229E, the extreme susceptibility of DCs to infection probably pre-
vents this virus from using them as a “Trojan horse.” Although
this hypothesis needs to be further supported by experimental
data, it was recently shown that DCs infected by Legionella pneu-
mophila undergo apoptosis to restrict bacterial replication and
spreading (34). Interestingly, SARS-CoV, which spreads to the
lower respiratory tract and is therefore associated with a much
more severe respiratory disease than HCoV-229E, does not induce
massive cell death and cytopathic effects in DCs, arguing in favor
of this hypothesis.
Our most striking observation is that, compared to DCs,
monocytes from the same donors are resistant to HCoV-229E
infection. However, when stimulated for only 24 h with IL-4
alone, and to some extent with GM-CSF alone, monocyte cultures
became susceptible to infection. This suggests that signaling
events induced by IL-4, and also somewhat induced by GM-CSF,
are responsible for monocyte sensitization to HCoV-229E infec-
tion. For example, both IL-4 and GM-CSF lead to the activation of
phosphatidylinositol 3-kinase and GRB2/mitogen-activated pro-
tein kinase pathways, which seem to be critical in the biological
functions of DCs (23, 25). In a previously published work, Collins
et al. found that monocytes/macrophages undergo apoptosis
when infected with HCoV-229E (11). However, these authors did
not describe the massive cell death and cytopathic effects that we
observed in Mo-DCs. This difference could be due to different cell
isolation and purification methods. Indeed, monocytes obtained
by adhering peripheral blood mononuclear cells quickly differen-
tiate into macrophages, as acknowledged by the authors them-
selves. This could account for their susceptibility to HCoV-229E
infection, whereas monocytes positively selected by magnetic
beads are resistant, as shown in the present report.
What are the mechanisms allowing monocytes, but not DCs, to
prevent cell death and massive cytopathic effects upon HCoV-
229E infection? We observed that monocytes produced 16 times
more IL-6 than did Mo-DCs upon infection. This could explain
the resistance of monocytes since IL-6 is an IFN-like cytokine with
antiviral properties. However, neutralizing IL-6 in infected mono-
cyte cultures did not confer susceptibility to HCoV-229E, and
adding recombinant IL-6 into infected DC cultures did not confer
resistance to the virus (data not shown). As well, supernatants
collected from infected monocytes did not protect Mo-DCs. Thus,
a soluble cofactor does not account for monocyte resistance to
HCoV-229E infection. Interestingly, it has been shown that bo-
vine viral diarrhea virus, a positive-strand RNA virus that belongs
to the Flaviviridae family, has opposite effects on these two cell
types, DCs being resistant, whereas monocytes are rapidly killed
by the infection (21). HIV is another example demonstrating that
cells from the macrophage lineage have different levels of suscep-
tibility to infection. Although macrophages and monocytes both
express HIV-1 entry receptors, monocytes freshly purified from
peripheral blood are resistant to HIV-1 infection. In contrast,
monocyte-derived macrophages are highly susceptible to infec-
tion. As an explanation for this, Wang et al. demonstrated that
freshly isolated monocytes express higher levels of anti-HIV-1
microRNAs than monocyte-derived macrophages (50). This sug-
gests that the expression of specific antiviral miRNA is a possible
mechanism underlying monocyte resistance to HCoV-229E. The
precise mechanism that triggers the susceptibility of monocytes to
infection after a short stimulation with IL-4 or GM-CSF remains
to be elucidated.
In conclusion, we demonstrate here that HCoV-229E, which is
commonly spread among human population, infects and destroys
human Mo-DCs rapidly, whereas monocytes are resistant. The
next step of this work is to identify not only the molecular basis of
the DC susceptibility and monocyte resistance to HCoV-229E in-
fection but also the mechanisms that regulate this phenotype and
how this affects the severity of the disease.
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